Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Virtual Behavioural Health Integration into Primary Care ? A Clinical Trial
Special Issue Article: Clinical Trails 2020
Biosimilars: Global Acceptance, Importance of Regulatory Consistency and current trends
Special Issue Article: Biosimilars Summit 2020
Translational Oncology Research and its Clinical impact using pioneering examples
Special Issue Article: Biosimilars Summit 2020
Packaging Challenge for Affordable Biosimilar Products
Special Issue Article: Biosimilars Summit 2020
Role of Women in the Study of Analgesic activity of Holarrhena antidysenterica leaves extract
Special Issue Article: Biosimilars Summit 2020
Biomanufacturing Programmes for Early Phase mAb Development
Special Issue Article: Biosimilars Summit 2020
in vitro screening of cytotoxic activities of hopea ponga (dennst.) Bark extracts
Special Issue Article: Biosimilars Summit 2020
In Vivo Anti-Inflammatory Activity Of Pajanelia Longifoliabark Extracts
Special Issue Article: Biosimilars Summit 2020
Biosimilars Summit & Clinical Trails 2020_Past conference Report
Special Issue Article: Biosimilars Summit & Clinical Trails 2020_Past conference Report
Illegal Trafficking of Banned Drugs of Having Adverse Effect on Human Health.
Special Issue Article: Clinical Trails 2020
Special Issue Article: Clinical Trails 2020
Financial and Economic Criteria for Evaluating the Performance of Pharmacies
Special Issue Article: Clinical Trails 2020
Special Issue Article: Biosimilars Summit 2020
A Comprehensive and Multidisciplinary Methodology to Improve Biosimilar Uptake in the United States
Special Issue Article: Biosimilars Summit 2020
Special Issue Article: Biosimilars Summit 2020
Cage Match: Inter Partes Review and Post Grant Review vs. Biologics and Biosimilars
Special Issue Article: Biosimilars Summit 2020
Biosimilars Interchangeability in the USA: The Final US-FDA Guidance to Industry
Special Issue Article: Biosimilars Summit 2020
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals